1. Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction. (August 2016) Authors: Distelmaier, K.; Schrutka, L.; Wurm, R.; Seidl, V.; Arfsten, H.; Cho, A.; Manjunatha, S.; Perkmann, T.; Strunk, G.; Lang, I.M.; Adlbrecht, C. Journal: Atherosclerosis Issue: Volume 251(2016) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deficiency of secreted IgM antibodies causes increased plasma IgE levels that promote atherosclerosis. (September 2016) Authors: Tsiantoulas, D.; Bot, I.; Kiss, M.; Bartolini-Gritti, B.; Göderle, L.; Ozsvar-Kozma, M.; Perkmann, T.; Hartvigsen, K.; Bergthaler, A.; Conrad, D.H.; Kuiper, J.; Mallat, Z.; Jumaa, H.; Binder, C.J. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Arterial stiffness in acute COVID‐19 and potential associations with clinical outcome. (21st March 2021) Authors: Schnaubelt, S.; Oppenauer, J.; Tihanyi, D.; Mueller, M.; Maldonado‐Gonzalez, E.; Zejnilovic, S.; Haslacher, H.; Perkmann, T.; Strassl, R.; Anders, S.; Stefenelli, T.; Zehetmayer, S.; Koppensteiner, R.; Domanovits, H.; Schlager, O. Journal: Journal of internal medicine Issue: Volume 290:Number 2(2021) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study. Issue 5 (12th December 2017) Authors: Eckl‐Dorna, J.; Fröschl, R.; Lupinek, C.; Kiss, R.; Gattinger, P.; Marth, K.; Campana, R.; Mittermann, I.; Blatt, K.; Valent, P.; Selb, R.; Mayer, A.; Gangl, K.; Steiner, I.; Gamper, J.; Perkmann, T.; Zieglmayer, P.; Gevaert, P.; Valenta, R.; Niederberger, V. Journal: Allergy Issue: Volume 73:Issue 5(2018) Page Start: 1003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Disparate effects of adalimumab and fumaric acid esters on cardiovascular risk factors in psoriasis patients: results from a prospective, randomized, observer‐blinded head‐to‐head trial. (2nd July 2020) Authors: Holzer, G.; Hoke, M.; Sabeti‐Sandor, S.; Perkmann, T.; Rauscher, A.; Strassegger, B.; Radakovic, S.; Tanew, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction. (August 2016) Authors: Distelmaier, K.; Schrutka, L.; Wurm, R.; Seidl, V.; Arfsten, H.; Cho, A.; Manjunatha, S.; Perkmann, T.; Strunk, G.; Lang, I.M.; Adlbrecht, C. Journal: Atherosclerosis Issue: Volume 251(2016) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia. (28th July 2017) Authors: Skrabs, C.; Pickl, W. F.; Perkmann, T.; Jäger, U.; Gessl, A. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 43:Number 1(2018) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Chronic inflammation predicts long‐term mortality in patients with Raynaud's phenomenon. (14th November 2017) Authors: Mueller, M.; Gschwandtner, M. E.; Gamper, J.; Giurgea, G.‐A.; Kiener, H. P.; Perkmann, T.; Koppensteiner, R.; Schlager, O. Journal: Journal of internal medicine Issue: Volume 283:Number 3(2018) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗